Amphastar pharmaceuticals reports q4 revenue of $83.4 mln

Amphastar pharmaceuticals reports financial results for the three months and full year ended december 31, 2019.q4 gaap loss per share $0.02.q4 revenue $83.4 million versus refinitiv ibes estimate of $81.8 million.q4 adjusted non-gaap earnings per share $0.07.q4 earnings per share estimate $0.07 -- refinitiv ibes data.
AMPH Ratings Summary
AMPH Quant Ranking